Successful Pregnancy Outcome with Comprehensive Treatment after 13 Consecutive Pregnancy Losses
Bao Shihua,Hong Liao,Shuai Wen,Lei Wang,Hu Jingjing
DOI: https://doi.org/10.1097/00029330-201409200-00027
2014-01-01
Abstract:Recurrent pregnancy loss (RPL) is defined as two or more failed clinical pregnancies. Up to 50% of RPL does not have a clear etiology.1 Increased resistance to blood flow in the uterine arteries has been found in women with unexplained RPL, and even greater resistance has been detected in women with RPL and auto-antibodies.2 However, vascular changes and pregnancy outcomes after the treatment for RPL patients with abnormal uterine artery flow remain poorly studied. This study was approved by the ethics review board of Shanghai First Maternity and Infant Hospital, and written consent was obtained from the patient. Here, we report a case of a 35-year-old woman, with a history of 13 consecutive miscarriages, who successfully delivered a live baby after receiving comprehensive treatment with prednisone, aspirin and low-molecularweight heparin (LMWH). This outcome demonstrates the effectiveness of this combination treatment on RPL associated with anti-SSA antibodies and abnormal uterine artery resistance. The 35-year-old woman (weight 55 kg; height 160 cm) presented to our clinic with a history of 13 consecutive miscarriages at 6-9 weeks of gestation, for which she had received treatment at other hospitals from 2003 to 2012. She had no significant medical or surgical history with negative for genetic, anatomic, endocrinologic, infectious, thrombophilia and auto-immune tests. The above tests were repeated at our hospital, and only the anti-SSA antibody assay was positive. Her husband’s semen analysis was normal. The treatment history of the patient has been shown in Table 1.Table 1: Treatment history of the patientAnalysis of her previous treatments showed that active immunotherapy and luteal support therapy were ineffective; however, early prednisone and aspirin treatment was followed by the detection of a fetal heart beat and an embryo on ultrasonography before pregnancy loss. Anti-SSA antibodies remained positive. In her 14th pregnancy, we increased the dose of prednisone from 5.0 mg/d to 7.5 mg/d and aspirin from 50 mg/d to 75 mg/d; in addition to administered 4 100 U LMWH b.i.d. β-human chorionic gonadotropin (hcG) level increased satisfactorily. At 7 weeks of gestation, the left uterine artery showed early-diastole flow reversal and the right uterine artery showed increased resistance (resistance index: 0.91; systole/diastole: 10.8) on Doppler ultrasonography (Figure 1). The dose of LMWH increased 4 100 U t.i.d, and by 9 gestational weeks, arterial resistance had normalized. Ultrasonographic screening for Down syndrome during early pregnancy revealed the following: head-arm diameter, 70 mm; fetal heart rate, 150/min, regular; nuchal translucency, 2.2 mm; placental position, posterior wall; placental thickness, 14 mm; placental grade, 0; distance of lower edge of placenta from the internal os, 22 mm; and depth of amniotic fluid, 35 mm. Drug treatment was discontinued at 12 weeks, and the patient was carefully followed-up throughout pregnancy. A baby girl was delivered weighing 2 650 g with an Apgar score of 10 on September 1st, 2012 at 38 weeks of gestation. Postpartum follow-up is ongoing. Her postpartum blood glucose level was high, but returned to normal after medication. The growth and development indexes and motor, language, sensory, neurological and mental development of the infant have been normal.Figure 1.: Uterine arterial resistance on Doppler ultrasonography at 7 weeks of gestation. A: the left uterine artery showed early-diastole flow reversal. B: the right uterine artery showed increased resistance.In our patient, anti-SSA antibodies and increased uterine arterial resistance were considered to have caused 13 miscarriages. Comprehensive treatment for both these findings was successful and resulted in the birth of a live baby girl in her 14th pregnancy. Many studies have attributed RPL to abnormal hormone levels. Progesterone plays a very important role in early pregnancy; and many reports have demonstrated the efficacy of progesterone support in maintaining pregnancy in RPL patients. However, progesterone and hCG treatments were unsuccessful in this patient. Impaired uterine artery flow has also been reported in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. Histopathological studies have demonstrated marked atherosis of the spiral arteries in women with antiphospholipid antibodies. Pulsed Doppler ultrasonography can be used to non-invasively evaluate uterine arterial impedance; this method provides physiologic data, rather than anatomic information and coagulation tests. We detected early-diastole flow reversal and increased resistance in the uterine arteries in our patient on Doppler ultrasonography. Low-dose aspirin irreversibly inhibits almost all platelet cyclo-oxygenase activity, thereby blocking thromboxane synthesis, a vasoconstrictor and platelet-aggregating agent. Aspirin also improves uterine artery blood flow.3 In the 13th pregnancy in our patient, the fetal heartbeat disappeared after treatment with 75 mg aspirin and 8 200 U LMWH. The same combination treatment was administered in her 14th pregnancy, and early-diastole flow reversal and increased resistance were detected in the right and left uterine arteries, respectively, during Doppler ultrasonography at 7 weeks of gestation. The LMWH dose was therefore increased to 4 100 U t.i.d, and at 9 weeks, the arterial resistance returned to normal. In addition to inhibiting coagulation, LMWH also limits damage by limiting antibodies that target trophoblasts, enhancing trophoblast invasiveness.4 In the successful pregnancy, combined aspirin and LMWH significantly decreased uterine artery resistance. According to Lin et al, platelet aggregation and clotting function was monitored closed to prevent overmedication.5 Anti-SSA antibodies have been closely linked with the development of various clinical manifestations in neonates, such as coronary artery blockage and neonatal lupus erythematosus; however, the incidence of fetal loss among anti-SSA antibody-positive mothers remains unknown. Since anti-SSA antibodies were detected, we treated the patient with prednisone. We increased the prednisone dose from 5 mg/d in her previous pregnancy to 7.5 mg/d, after considering her medication history, weight and potential side effects. In conclusion, uterine artery blood flow measurement can identify impaired uterine circulation in women with RPL. Aspirin and LMWH corrected the increased resistance to uterine artery blood flow and resulted in a successful pregnancy. However, large prospective randomized trials will determine the optimal treatment modality in RPL patients. Acknowledgements: We are grateful to Prof. Joanne Kwak-Kim (Director, Reproductive Medicine; Professor, Department of Obstetrics and Gynecology, Chicago Medical School at Rosalind Franklin University of Medicine and Science) for her very helpful comments.